Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 11 for Irritable bowel syndrome

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

    Rochester, MN

  2. A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis

    Rochester, MN

  3. A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome

    Jacksonville, FL

  4. A Study Evaluating the Use of Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients

    Jacksonville, FL

  5. A Study of Eluxadoline in Participants with Irritable Bowel Syndrome with Diarrhea (IBS-D) Who Have Evidence of Bile Acid Malabsorption (BAM)

    Rochester, MN

  6. A Biobank for Functional Gastrointestinal Disorders (FGID)

    Rochester, MN

  7. Obesity and IBS as likely associated comorbidities

    Scottsdale/Phoenix, AZ

  8. Simplifying the Diagnosis of Bile Acid Malabsorption: Fasting Serum C4 and Proportion of Primary Bile Acids Measured from a Random, Single Stool Sample

    Rochester, MN

  9. Bile Acids, Genetic Control and Ileo-Colonic Mucosal Expression in Irritable Bowel Syndrome-Diarrhea (IBS-D)

    Rochester, MN

  10. Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders

    Rochester, MN

.

Mayo Clinic Footer